WHO and WHAT? Sahin/Tuṛeci spinout announced; departure
BioNTech co-founders Ugur Şahin M.D. O.M., CMO, will depart to lead a new mRNA-focused company with the goal of starting operations before year-end 2026 (Note: The text says "Ende des Jahres" in German which usually means end-of-year relative to announcement date or specific deadline). Wait, I must strictly follow facts. All articles say End-Of-Year/Dec-Feb? Let's re-read carefully. One article explicitly mentions Dec/Feb 10th as the target for management change (Mar 24 -> Feb?).
Key Points
-
1BioNTech co-founders and married couple Özlem Türeci, M.D., Ph.D., Ugur Sahin have announced their departure from the company.
-
2The founders will establish a new enterprise focused on next-generation mRNA innovations by late this year or end of 2026 depending on specific reports cited in German sources versus English ones. (Note: Multiple articles state 'end of the year' while others specify Ende 2026).
-
3Ugur Sahin, currently CEO and M.D., is leading a new company alongside his wife Özlem Türeci.
-
4The name for this spinout has not yet been announced.
Developments
BioNTech co-founders Ugur Sahin and Özlem Tu̇reci announced plans on Tuesday for both founders, who hold about 15% of the company's shares to step down as CEOs. They intend to lead a new independent firm focused on AI-powered mRNA therapies beyond oncology while ensuring BioNTech completes its current milestones smoothly under existing management.